Provided by Tiger Fintech (Singapore) Pte. Ltd.

Magenta Therapeutics Inc.

11.19
+0.0000
Volume:- -
Turnover:268.84K
Market Cap:42.24M
PE:-0.61
High:11.19
Open:11.19
Low:11.19
Close:11.19
Loading ...
Apr 06, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Major Issues Report

8-K - Current report
Feb 02, 2023

Major Issues Report

8-K - Current report
Jan 25, 2023

Major Issues Report

8-K - Current report
Dec 20, 2022

Major Issues Report

8-K - Current report
Dec 13, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 27, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 26, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 17, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Correspondence

CORRESP [Cover] - Correspondence